Symphogen: Servier Completes the Acquisition of Symphogen
Symphogen will now function as Servier's antibody center of excellence across multiple therapeutic areas, including oncology. Symphogen
Read full article »
Symphogen is a biopharmaceutical company that researches and develops antibody therapeutics for the treatment of cancer.
Read more